ENU mutagenesis identifies mice with mithochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease

Jer Yuarn Wu, Hsiao Jung Kao, Sing Chung Li, Robert Stevens, Steven Hillman, David Millington, Yuan Tsong Chen

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Tandem mass spectrometry was applied to detect derangements in the pathways of amino acid and fatty acid metabolism in N-ethyl-N-nitrosourea-treated (ENU-treated) mice. We identified mice with marked elevation of blood branched-chain amino acids (BCAAs), ketoaciduria, and clinical features resembling human maple syrup urine disease (MSUD), a severe genetic metabolic disorder caused by the deficiency of branched-chain α-keto acid dehydrogenase (BCKD) complex. However, the BCKD genes and enzyme activity were normal. Sequencing of branched-chain aminotransferase genes (Bcat) showed no mutation in the cytoplasmic isoform (Bcat-1) but revealed a homozygous splice site mutation in the mitochondrial isoform (Bcat-2). The mutation caused a deletion of exon 2, a marked decrease in Bcat-2 mRNA, and a deficiency in both BCAT-2 protein and its enzyme activity. Affected mice responded to a BCAA-restricted diet with amelioration of the clinical symptoms and normalization of the amino acid pattern. We conclude that BCAT-2 deficiency in the mouse can cause a disease that mimics human MSUD. These mice provide an important animal model for study of BCAA metabolism and its toxicity. Metabolomics-guided screening, coupled with ENU mutagenesis, is a powerful approach in uncovering novel enzyme deficiencies and recognizing important pathways of genetic metabolic disorders.

Original languageEnglish
Pages (from-to)434-440
Number of pages7
JournalJournal of Clinical Investigation
Volume113
Issue number3
DOIs
Publication statusPublished - Feb 2004
Externally publishedYes

Fingerprint

Maple Syrup Urine Disease
Mutagenesis
Branched Chain Amino Acids
3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)
Inborn Genetic Diseases
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase
Genes
Mutation
Protein Isoforms
Ethylnitrosourea
Amino Acids
Ketosis
Metabolomics
Enzymes
Tandem Mass Spectrometry
Metabolic Networks and Pathways
Exons
Fatty Acids
Animal Models
branched-chain-amino-acid transaminase

ASJC Scopus subject areas

  • Medicine(all)

Cite this

ENU mutagenesis identifies mice with mithochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease. / Wu, Jer Yuarn; Kao, Hsiao Jung; Li, Sing Chung; Stevens, Robert; Hillman, Steven; Millington, David; Chen, Yuan Tsong.

In: Journal of Clinical Investigation, Vol. 113, No. 3, 02.2004, p. 434-440.

Research output: Contribution to journalArticle

Wu, Jer Yuarn ; Kao, Hsiao Jung ; Li, Sing Chung ; Stevens, Robert ; Hillman, Steven ; Millington, David ; Chen, Yuan Tsong. / ENU mutagenesis identifies mice with mithochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease. In: Journal of Clinical Investigation. 2004 ; Vol. 113, No. 3. pp. 434-440.
@article{c2dc9bbaf6cf44ff9d3b22ef3f3a3092,
title = "ENU mutagenesis identifies mice with mithochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease",
abstract = "Tandem mass spectrometry was applied to detect derangements in the pathways of amino acid and fatty acid metabolism in N-ethyl-N-nitrosourea-treated (ENU-treated) mice. We identified mice with marked elevation of blood branched-chain amino acids (BCAAs), ketoaciduria, and clinical features resembling human maple syrup urine disease (MSUD), a severe genetic metabolic disorder caused by the deficiency of branched-chain α-keto acid dehydrogenase (BCKD) complex. However, the BCKD genes and enzyme activity were normal. Sequencing of branched-chain aminotransferase genes (Bcat) showed no mutation in the cytoplasmic isoform (Bcat-1) but revealed a homozygous splice site mutation in the mitochondrial isoform (Bcat-2). The mutation caused a deletion of exon 2, a marked decrease in Bcat-2 mRNA, and a deficiency in both BCAT-2 protein and its enzyme activity. Affected mice responded to a BCAA-restricted diet with amelioration of the clinical symptoms and normalization of the amino acid pattern. We conclude that BCAT-2 deficiency in the mouse can cause a disease that mimics human MSUD. These mice provide an important animal model for study of BCAA metabolism and its toxicity. Metabolomics-guided screening, coupled with ENU mutagenesis, is a powerful approach in uncovering novel enzyme deficiencies and recognizing important pathways of genetic metabolic disorders.",
author = "Wu, {Jer Yuarn} and Kao, {Hsiao Jung} and Li, {Sing Chung} and Robert Stevens and Steven Hillman and David Millington and Chen, {Yuan Tsong}",
year = "2004",
month = "2",
doi = "10.1172/JCI200419574",
language = "English",
volume = "113",
pages = "434--440",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "3",

}

TY - JOUR

T1 - ENU mutagenesis identifies mice with mithochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease

AU - Wu, Jer Yuarn

AU - Kao, Hsiao Jung

AU - Li, Sing Chung

AU - Stevens, Robert

AU - Hillman, Steven

AU - Millington, David

AU - Chen, Yuan Tsong

PY - 2004/2

Y1 - 2004/2

N2 - Tandem mass spectrometry was applied to detect derangements in the pathways of amino acid and fatty acid metabolism in N-ethyl-N-nitrosourea-treated (ENU-treated) mice. We identified mice with marked elevation of blood branched-chain amino acids (BCAAs), ketoaciduria, and clinical features resembling human maple syrup urine disease (MSUD), a severe genetic metabolic disorder caused by the deficiency of branched-chain α-keto acid dehydrogenase (BCKD) complex. However, the BCKD genes and enzyme activity were normal. Sequencing of branched-chain aminotransferase genes (Bcat) showed no mutation in the cytoplasmic isoform (Bcat-1) but revealed a homozygous splice site mutation in the mitochondrial isoform (Bcat-2). The mutation caused a deletion of exon 2, a marked decrease in Bcat-2 mRNA, and a deficiency in both BCAT-2 protein and its enzyme activity. Affected mice responded to a BCAA-restricted diet with amelioration of the clinical symptoms and normalization of the amino acid pattern. We conclude that BCAT-2 deficiency in the mouse can cause a disease that mimics human MSUD. These mice provide an important animal model for study of BCAA metabolism and its toxicity. Metabolomics-guided screening, coupled with ENU mutagenesis, is a powerful approach in uncovering novel enzyme deficiencies and recognizing important pathways of genetic metabolic disorders.

AB - Tandem mass spectrometry was applied to detect derangements in the pathways of amino acid and fatty acid metabolism in N-ethyl-N-nitrosourea-treated (ENU-treated) mice. We identified mice with marked elevation of blood branched-chain amino acids (BCAAs), ketoaciduria, and clinical features resembling human maple syrup urine disease (MSUD), a severe genetic metabolic disorder caused by the deficiency of branched-chain α-keto acid dehydrogenase (BCKD) complex. However, the BCKD genes and enzyme activity were normal. Sequencing of branched-chain aminotransferase genes (Bcat) showed no mutation in the cytoplasmic isoform (Bcat-1) but revealed a homozygous splice site mutation in the mitochondrial isoform (Bcat-2). The mutation caused a deletion of exon 2, a marked decrease in Bcat-2 mRNA, and a deficiency in both BCAT-2 protein and its enzyme activity. Affected mice responded to a BCAA-restricted diet with amelioration of the clinical symptoms and normalization of the amino acid pattern. We conclude that BCAT-2 deficiency in the mouse can cause a disease that mimics human MSUD. These mice provide an important animal model for study of BCAA metabolism and its toxicity. Metabolomics-guided screening, coupled with ENU mutagenesis, is a powerful approach in uncovering novel enzyme deficiencies and recognizing important pathways of genetic metabolic disorders.

UR - http://www.scopus.com/inward/record.url?scp=1542347757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542347757&partnerID=8YFLogxK

U2 - 10.1172/JCI200419574

DO - 10.1172/JCI200419574

M3 - Article

VL - 113

SP - 434

EP - 440

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 3

ER -